Key Milestone Completion Date Announced by Imaging3

Imaging3 Announces Date for the Beta Release of the Company's Revolutionary Technology; CEO Featured in PRBroadcast.com Online Interview


BURBANK, Calif., Sept. 28, 2006 (PRIMEZONE) -- Imaging3(tm), Inc. (OTCBB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, today announced that the company is presently featured in an online follow up interview at www.PRBroadcast.com. Mr. Dean Janes, CEO of Imaging3, discusses upcoming projects, recent developments, and the highly anticipated release of the company's 3D real-time medical imaging device, The Dominion(tm). The prototype is set for completion on October 31 of this year so that the company can exhibit the finished product at the Radiological Society of North America (RSNA) tradeshow in late November.

In addition to the announcement of the upcoming completion date of the prototype, Imaging3's CEO revealed that the company anticipates announcing significant partnerships for beta-testing the Dominion at two world-renowned university hospitals located in Southern California.

The Dominion's revolutionary mobile, three-dimensional, real-time medical diagnostic technology represents a turning point in medical imaging and will enable new procedures not possible today and is expected to improve existing procedures through increased speed and greater accuracy. In addition to 3D real-time fluoroscopic imaging, the Dominion is capable of emulating other medical imaging technology, such as CT scans, and yet does so at a fraction of the cost. Emphasizing this, the company's CEO, Dean Janes, said "This is not only breakthrough technology, it is lifesaving technology."

The IMGG interview is available at www.PRBroadcast.com. To access the interview, click on "Join Now/Log In" in the upper right corner. Non-subscribers to PRBroadcast.com will be asked to complete a short registration form to access the interview.

About Imaging3

Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at www.imaging3.com for more information.

Safe Harbor Statement

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive, and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the Company.



            

Contact Data